000 01016 a2200265 4500
005 20250518052314.0
264 0 _c20191206
008 201912s 0 0 eng d
022 _a1365-4632
024 7 _a10.1111/ijd.14516
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIanhez, Mayra
245 0 0 _aResponse to the correspondence: a randomized, open, controlled trial of tretinoin 0.05% cream vs. low-dose oral isotretinoin for the treatment of field cancerization.
_h[electronic resource]
260 _bInternational journal of dermatology
_c10 2019
300 _ae186-e187 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAdministration, Cutaneous
650 0 4 _aIsotretinoin
650 0 4 _aTretinoin
700 1 _aPinto, Sebastião A
700 1 _aBagatin, Ediléia
700 1 _aMiot, Helio A
773 0 _tInternational journal of dermatology
_gvol. 58
_gno. 10
_gp. e186-e187
856 4 0 _uhttps://doi.org/10.1111/ijd.14516
_zAvailable from publisher's website
999 _c29945040
_d29945040